26 August 2022
Asian patient groups have placed the pharmaceutical company first for corporate reputation in Asia.
Tag: Pfizer
22 July 2022
IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?
8 June 2022
There will be no charge for the Covid-19 antiviral drug, Paxlovid, provided in private hospitals, except for consultation fees and other hospital charges.
26 May 2022
Pfizer's "An Accord for a Healthier World" initiative will provide all its current and future patent-protected medicines and vaccines on a not-for-profit basis to 45 lower-income countries.
12 May 2022
The Covid-19 pill is prioritised for Covid-19 patients with mild to moderate symptoms who do not need oxygen support, but have underlying disease like diabetes, hypertension, kidney problems, asthma or chronic lung conditions, heart disease, and cancer.
14 April 2022
Paxlovid will be prioritised for the elderly and patients with several comorbidities and are immunocompromised.
31 March 2022
The drugs approved for Covid-19 treatment are: Roche’s Ronapreve solution, Glenmark’s Fabiflu tablets, Lilly Del Caribe’s Olumiant tablets, and Pfizer’s Paxlovid tablets.
24 March 2022
Pfizer signed an agreement with Unicef to supply up to 4 million treatment courses of Paxlovid, with supply expected to be available for orders next month.
22 March 2022
The Medicines Patent Pool signed agreements with 35 generic manufacturers from 12 countries, including Vietnam, to produce generics of Paxlovid for 95 low- and middle-income countries.
20 May 2021
The Pakatan Harapan Covid-19 vaccination committee says state governments and private health care providers should be allowed to procure their own Covid-19 vaccine supply and inoculate paying customers.